birb 796 has been researched along with panobinostat in 1 studies
Studies (birb 796) | Trials (birb 796) | Recent Studies (post-2010) (birb 796) | Studies (panobinostat) | Trials (panobinostat) | Recent Studies (post-2010) (panobinostat) |
---|---|---|---|---|---|
137 | 5 | 80 | 678 | 95 | 593 |
Protein | Taxonomy | birb 796 (IC50) | panobinostat (IC50) |
---|---|---|---|
Histone deacetylase 8 | Schistosoma mansoni | 0.45 | |
Histone deacetylase 3 | Homo sapiens (human) | 0.2031 | |
Bromodomain-containing protein 4 | Homo sapiens (human) | 0.005 | |
Cytochrome P450 3A5 | Homo sapiens (human) | 0.0033 | |
Histone deacetylase 4 | Homo sapiens (human) | 0.3792 | |
Histone deacetylase 1 | Homo sapiens (human) | 0.181 | |
Histone deacetylase 7 | Homo sapiens (human) | 0.9434 | |
Histone deacetylase 2 | Homo sapiens (human) | 0.2527 | |
Polyamine deacetylase HDAC10 | Homo sapiens (human) | 0.007 | |
Histone deacetylase 11 | Homo sapiens (human) | 0.8396 | |
Histone deacetylase 8 | Homo sapiens (human) | 0.46 | |
Histone deacetylase 6 | Homo sapiens (human) | 0.2307 | |
Histone deacetylase 9 | Homo sapiens (human) | 0.5825 | |
Histone deacetylase 5 | Homo sapiens (human) | 0.3424 | |
Histone deacetylase | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0025 | |
Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.002 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baccarani, M; Iacobucci, I; Martinelli, G; Soverini, S | 1 |
1 other study(ies) available for birb 796 and panobinostat
Article | Year |
---|---|
Targeted therapy and the T315I mutation in Philadelphia-positive leukemias.
Topics: Adenosine Triphosphate; Amino Acid Substitution; Antineoplastic Agents; Benzamides; Benzene Derivatives; Clinical Trials as Topic; Drug Delivery Systems; Drug Design; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Genes, abl; Humans; Hydrogen Bonding; Hydroxamic Acids; Imatinib Mesylate; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation, Missense; Naphthalenes; Panobinostat; Philadelphia Chromosome; Piperazines; Point Mutation; Protein Binding; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Remission Induction; Structure-Activity Relationship; Threonine; Vorinostat | 2007 |